Health-related quality of life for pediatric patients with end-stage kidney disease: A systematic review and meta-analysis of the Pediatric Quality of Life Inventory (PedsQL)
- PMID: 38468403
- DOI: 10.1111/hdi.13138
Health-related quality of life for pediatric patients with end-stage kidney disease: A systematic review and meta-analysis of the Pediatric Quality of Life Inventory (PedsQL)
Abstract
Introduction: Health-related quality of life (HRQoL) studies demonstrate the impact of end-stage renal disease (ESRD) on the physical and psychosocial development of children. While several instruments are used to measure HRQoL, few have standardized domains specific to pediatric ESRD. This review examines current evidence on self and proxy-reported HRQoL among pediatric patients with ESRD, based on the Pediatric Quality of Life Inventory (PedsQL) questionnaires.
Methods: Following PRISMA guidelines, we conducted a systematic review and meta-analysis on HRQoL using the PedsQL 4.0 Generic Core Scale (GCS) and the PedsQL 3.0 ESRD Module among 5- to 18-year-old patients. We queried PubMed, Embase, Web of Science, CINAHL, and Cochrane databases. Retrospective, case-controlled, and cross-sectional studies using PedsQL were included.
Findings: Of 435 identified studies, 14 met inclusion criteria administered in several countries. Meta-analysis demonstrated a significantly higher total HRQoL for healthy patients over those with ESRD (SMD:1.44 [95% CI: 0.78-2.09]) across all dimensional scores. In addition, kidney transplant patients reported a significantly higher HRQoL than those on dialysis (PedsQL GCS, SMD: 0.33 [95% CI: 0.14-0.53]) and (PedsQL ESRD, SMD: 0.65 [95% CI: 0.39-0.90]) concordant with parent-proxy reports.
Discussion: Patients with ESRD reported lower HRQoL in physical and psychosocial domains compared with healthy controls, while transplant and peritoneal dialysis patients reported better HRQoL than those on hemodialysis. This analysis demonstrates the need to identify dimensions of impaired functioning and produce congruent clinical interventions. Further research on the impact of individual comorbidities in HRQoL is necessary for developing comprehensive, integrated, and holistic treatment programs.
Keywords: chronic kidney disease (CKD); end‐stage renal disease (ESRD); health‐related quality of life (HRQoL); hemodialysis (HD); peritoneal dialysis (PD); renal replacement therapy (RRT).
© 2024 International Society for Hemodialysis.
Similar articles
-
Quality of life in children with end-stage renal disease based on a PedsQL ESRD module.Pediatr Nephrol. 2012 Dec;27(12):2293-300. doi: 10.1007/s00467-012-2262-1. Epub 2012 Jul 26. Pediatr Nephrol. 2012. PMID: 22832667
-
Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis.Pediatr Nephrol. 2009 Aug;24(8):1553-60. doi: 10.1007/s00467-009-1174-1. Epub 2009 May 7. Pediatr Nephrol. 2009. PMID: 19421787
-
Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL).Am J Kidney Dis. 2008 Feb;51(2):285-97. doi: 10.1053/j.ajkd.2007.09.021. Am J Kidney Dis. 2008. PMID: 18215706
-
Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis.Health Qual Life Outcomes. 2020 Jun 18;18(1):191. doi: 10.1186/s12955-020-01449-2. Health Qual Life Outcomes. 2020. PMID: 32552800 Free PMC article.
-
Psychosocial interventions for preventing and treating depression in dialysis patients.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3. Cochrane Database Syst Rev. 2019. PMID: 31789430 Free PMC article.
Cited by
-
Quality of life in people with chronic kidney disease: focusing on modifiable risk factors.Curr Opin Nephrol Hypertens. 2024 Nov 1;33(6):573-582. doi: 10.1097/MNH.0000000000001013. Epub 2024 Jul 22. Curr Opin Nephrol Hypertens. 2024. PMID: 39115435 Free PMC article. Review.
-
Rethinking the value of psychology: lessons in advocacy, kidney disease, and a day at the pool.Pediatr Nephrol. 2025 Aug;40(8):2427-2429. doi: 10.1007/s00467-025-06726-0. Epub 2025 Feb 27. Pediatr Nephrol. 2025. PMID: 40014134 No abstract available.
References
REFERENCES
-
- Kaspar CDW, Bholah R, Bunchman TE. A review of pediatric chronic kidney disease. Blood Purif. 2016;41(1‐3):211–217. https://doi.org/10.1159/000441737
-
- McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrol. 2019;30(1):127–135. https://doi.org/10.1681/ASN.2018050531
-
- Rees L, Schaefer F, Schmitt CP, Shroff R, Warady BA. Chronic dialysis in children and adolescents: challenges and outcomes. Lancet Child Adolesc Health. 2017;1(1):68–77. https://doi.org/10.1016/S2352-4642(17)30018-4
-
- Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of end‐stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107. https://doi.org/10.1159/000514550
-
- Abdel‐Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end‐stage kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1057–1064. https://doi.org/10.2215/CJN.00430109
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous